marginal significanceP =0.059
Kaplan–Meier estimates of the cumulative PFS for patients with methylated and non-methylated BRMS1 promoter had marginal significance ( P =0.059, log-rank test) whereas that of the cumulative OS was significantly different among the two groups ( P =0.003, log-rank test) ( Figure 2C ).